Wedbush reaffirmed their neutral rating on shares of Healthpeak Properties (NYSE:PEAK – Free Report) in a report released on Tuesday, Benzinga reports. Wedbush currently has a $19.00 price target on the stock. Several other analysts also recently weighed in on the stock. BNP Paribas assumed coverage on shares of Healthpeak Properties in a report on […]